Detailed Research: Economic Perspectives on CVS Health, FirstEnergy, Welbilt, Inc., Rockwell Collins, Sprouts Farmers Market, and Inovio Pharmaceuticals — What Drives Growth in Today's Competitive Lan

Detailed Research: Economic Perspectives on CVS Health, FirstEnergy, Welbilt, Inc., Rockwell Collins, Sprouts Farmers Market, and Inovio Pharmaceuticals — What Drives Growth in Today's Competitive Landscape

NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CVS Health Corporation (NYSE:CVS), FirstEnergy Corporation (NYSE:FE), Welbilt, Inc. (NYSE:WBT), Rockwell Collins, Inc. (NYSE:COL), Sprouts Farmers Market, Inc. (NASDAQ:SFM), and Inovio Pharmaceuticals, Inc. (NASDAQ:INO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CVS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVS
FE DOWNLOAD: http://Fundamental-Markets.com/register/?so=FE
WBT DOWNLOAD: http://Fundamental-Markets.com/register/?so=WBT
COL DOWNLOAD: http://Fundamental-Markets.com/register/?so=COL
SFM DOWNLOAD: http://Fundamental-Markets.com/register/?so=SFM
INO DOWNLOAD: http://Fundamental-Markets.com/register/?so=INO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine CVS Health Corporation (NYSE:CVS), FirstEnergy Corporation (NYSE:FE), Welbilt, Inc. (NYSE:WBT), Rockwell Collins, Inc. (NYSE:COL), Sprouts Farmers Market, Inc. (NASDAQ:SFM), and Inovio Pharmaceuticals, Inc. (NASDAQ:INO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 29th, 2017. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CVS HEALTH CORPORATION (CVS) REPORT OVERVIEW

CVS Health's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, CVS Health reported revenue of $46,181.00MM vs $44,615.00MM (up 3.51%) and basic earnings per share $1.26 vs $1.44 (down 12.50%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, CVS Health reported revenue of $177,526.00MM vs $153,290.00MM (up 15.81%) and basic earnings per share $4.93 vs $4.66 (up 5.79%). CVS Health is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.71. The estimated EPS forecast for the next fiscal year is $6.35 and is expected to report on February 8th, 2018.

To read the full CVS Health Corporation (CVS) report, download it here: http://Fundamental-Markets.com/register/?so=CVS

-----------------------------------------

FIRSTENERGY CORPORATION (FE) REPORT OVERVIEW

FirstEnergy's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, FirstEnergy reported revenue of $3,714.00MM vs $3,917.00MM (down 5.18%) and basic earnings per share $0.89 vs $0.89 (unchanged). For the twelve months ended December 31st, 2016 vs December 31st, 2015, FirstEnergy reported revenue of $14,562.00MM vs $15,026.00MM (down 3.09%) and basic earnings per share -$14.49 vs $1.37. FirstEnergy is expected to report earnings on February 20th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $2.51 and is expected to report on February 20th, 2018.

To read the full FirstEnergy Corporation (FE) report, download it here: http://Fundamental-Markets.com/register/?so=FE

-----------------------------------------

WELBILT, INC. (WBT) REPORT OVERVIEW

Welbilt's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Welbilt reported revenue of $380.40MM vs $384.00MM (down 0.94%) and basic earnings per share $0.24 vs $0.18 (up 33.33%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Welbilt reported revenue of $1,456.60MM vs $1,570.10MM (down 7.23%) and basic earnings per share $0.58 vs $1.15 (down 49.57%). Welbilt is expected to report earnings on February 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.16. The estimated EPS forecast for the next fiscal year is $0.94 and is expected to report on February 21st, 2018.

To read the full Welbilt, Inc. (WBT) report, download it here: http://Fundamental-Markets.com/register/?so=WBT

-----------------------------------------

ROCKWELL COLLINS, INC. (COL) REPORT OVERVIEW

Rockwell Collins' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Rockwell Collins reported revenue of $2,193.00MM vs $1,445.00MM (up 51.76%) and basic earnings per share $1.33 vs $1.59 (down 16.35%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Rockwell Collins reported revenue of $6,822.00MM vs $5,259.00MM (up 29.72%) and basic earnings per share $4.85 vs $5.58 (down 13.08%). Rockwell Collins is expected to report earnings on January 19th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.20. The estimated EPS forecast for the next fiscal year is $8.18 and is expected to report on October 26th, 2018.

To read the full Rockwell Collins, Inc. (COL) report, download it here: http://Fundamental-Markets.com/register/?so=COL

-----------------------------------------

SPROUTS FARMERS MARKET, INC. (SFM) REPORT OVERVIEW

Sprouts Farmers Market's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Sprouts Farmers Market reported revenue of $1,206.06MM vs $1,035.80MM (up 16.44%) and basic earnings per share $0.23 vs $0.16 (up 43.75%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Sprouts Farmers Market reported revenue of $4,046.39MM vs $3,593.03MM (up 12.62%) and basic earnings per share $0.84 vs $0.84 (unchanged). Sprouts Farmers Market is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.12. The estimated EPS forecast for the next fiscal year is $1.09 and is expected to report on February 22nd, 2018.

To read the full Sprouts Farmers Market, Inc. (SFM) report, download it here: http://Fundamental-Markets.com/register/?so=SFM

-----------------------------------------

INOVIO PHARMACEUTICALS, INC. (INO) REPORT OVERVIEW

Inovio Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Inovio Pharmaceuticals reported revenue of $2.64MM vs $12.54MM (down 78.91%) and basic earnings per share -$0.39 vs -$0.28. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Inovio Pharmaceuticals reported revenue of $35.37MM vs $40.57MM (down 12.83%) and basic earnings per share -$1.01 vs -$0.43. Inovio Pharmaceuticals is expected to report earnings on March 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.36. The estimated EPS forecast for the next fiscal year is -$1.28 and is expected to report on March 21st, 2018.

To read the full Inovio Pharmaceuticals, Inc. (INO) report, download it here: http://Fundamental-Markets.com/register/?so=INO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.